Prasad was an outspoken critic of vaccines, lockdowns and mask mandates during the Covid pandemic. In 2022, Prasad and Makary ...

The U.S. Food and Drug Administration said on Wednesday it will hold a meeting of experts on May 22 to discuss COVID-19 ...

A combination shot for flu and COVID-19 using messenger RNA generated antibodies in a study, but U.S. government regulators ...

The Food and Drug Administration (FDA) has named Indian American hematologist-oncologist Dr. Vinay Prasad, an outspoken ...

Dr. Vinay Prasad, the FDA's new vaccine chief, has been accused of spreading misinformation about Covid vaccines.

The advisory committee meeting is an important step in the process of readying boosters for the fall and winter season, but will take place amid newly imposed scrutiny of COVID shots.

Dr. Vinay Prasad, a prominent critic of the pharmaceutical industry and the Food and Drug Administration, has been named to oversee the agency’s program for vaccines and biotech drugs.

The appointment, announced May 6 by FDA Commissioner Dr. Marty Makary, places Prasad at the helm of one of the agency’s most ...

The U.S. Food and Drug Administration said on Wednesday it will hold a meeting of experts to discuss COVID-19 vaccine ...

In this week’s edition of InnovationRx, we look at Aetna’s withdrawal from the ACA exchanges, the potential for digital ...

The FDA has appointed hematologist-oncologist Vinay Prasad, MD, to lead the agency’s Center for Biologics Evaluation and Research, according to a May 6 NBC News report.  As the head of CBER, Dr.

Moderna’s study, involving 8,000 adults 50 and older, showed the new combo shot generated an immune response against COVID and most strains of flu compared to existing stand-alone shots.